What is the address of DR. T. SLANGEN?

The registered office of DR. T. SLANGEN is located at Alfons Servaislei 18 box 1, 2900 Schoten.

Is DR. T. SLANGEN still active?

Yes. According to the CBE (29 September 2026) DR. T. SLANGEN is active, legal situation “Normale toestand”, started on 16 January 2001.

Is DR. T. SLANGEN registered on Peppol?

Yes, DR. T. SLANGEN is registered on the Peppol network with ID 0208:0473830251.

What is the enterprise number of DR. T. SLANGEN?

The enterprise number of DR. T. SLANGEN is BE0473830251.

When was DR. T. SLANGEN founded?

DR. T. SLANGEN was founded on 16 January 2001.

Who are the directors of DR. T. SLANGEN?

According to the 2024 annual accounts, the directors of DR. T. SLANGEN are: Thomas Hugo Slangen.

Is DR. T. SLANGEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 January 2001; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did DR. T. SLANGEN make in 2024?

DR. T. SLANGEN posted a profit after taxes of € 22,137 in financial year 2024.

What is the revenue of DR. T. SLANGEN?

As a small company, DR. T. SLANGEN is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 61,159.

DR. T. SLANGEN (Private Limited) - Schoten - BE0473830251

Dossier DR. T. SLANGEN, printed on 29 September 2026 from databakkes.be/en/0473830251/dr-t-slangen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

DR. T. SLANGEN from Schoten, company number BE0473830251, closed financial year 2024 with a result of € 22,137 after tax. For that financial year DR. T. SLANGEN recorded a gross margin of € 61,159 and equity of € 120,010. Compared with financial year 2023, the result moved from € -21,121 to € 22,137. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.

What it is worth Growing

€ 120,010

▲ 23% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 22,137

▲ still € 21,121 loss in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 11,489

▲ € 10,965 vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 107,610.

People and assets in 2024

Vehicles and equipment

€ 51,943

▼ 14% vs 2023

Of which on lease € 49,439.

Debts at end 2024

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 168,679

▼ 28% vs 2023

€ 53,009 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 8,120

▲ 34% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 9,152

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 92,367 Gross margin 2021: € 92,367 First fiscal year in the series	€ 74,513 Gross margin 2022: € 74,513 ▼ 19% vs 2021 (€ 92,367) Unfavourable step	€ 17,374 Gross margin 2023: € 17,374 ▼ 77% vs 2022 (€ 74,513) Unfavourable step	€ 61,159 Gross margin 2024: € 61,159 ▲ 252% vs 2023 (€ 17,374) Favourable step	▲ 252%
Profit after taxes	€ 15,815 Profit after taxes 2021: € 15,815 First fiscal year in the series	€ 18,857 Profit after taxes 2022: € 18,857 ▲ 19% vs 2021 (€ 15,815) Favourable step	€ -21,121 Profit after taxes 2023: € -21,121 ▼ € 39,978 vs 2022 (€ 18,857) Unfavourable step	€ 22,137 Profit after taxes 2024: € 22,137 ▲ € 43,259 vs 2023 (€ -21,121) Favourable step	▲ € 43,259
Equity	€ 100,137 Equity 2021: € 100,137 First fiscal year in the series	€ 118,994 Equity 2022: € 118,994 ▲ 19% vs 2021 (€ 100,137) Favourable step	€ 97,873 Equity 2023: € 97,873 ▼ 18% vs 2022 (€ 118,994) Unfavourable step	€ 120,010 Equity 2024: € 120,010 ▲ 23% vs 2023 (€ 97,873) Favourable step	▲ 23%
Total debts	€ 273,544 Total debts 2021: € 273,544 First fiscal year in the series	€ 301,193 Total debts 2022: € 301,193 ▲ 10% vs 2021 (€ 273,544) Unfavourable step	€ 258,560 Total debts 2023: € 258,560 ▼ 14% vs 2022 (€ 301,193) Favourable step	€ 230,293 Total debts 2024: € 230,293 ▼ 11% vs 2023 (€ 258,560) Favourable step	▼ 11%
Cash	€ 5,440 Cash 2021: € 5,440 First fiscal year in the series	€ 5,057 Cash 2022: € 5,057 ▼ 7% vs 2021 (€ 5,440) Unfavourable step	€ 523 Cash 2023: € 523 ▼ 90% vs 2022 (€ 5,057) Unfavourable step	€ 11,489 Cash 2024: € 11,489 ▲ € 10,965 vs 2023 (€ 523) Favourable step	▲ € 10,965
Retained profit	€ 87,737 Retained profit 2021: € 87,737 First fiscal year in the series	€ 106,594 Retained profit 2022: € 106,594 ▲ 21% vs 2021 (€ 87,737) Favourable step	€ 85,473 Retained profit 2023: € 85,473 ▼ 20% vs 2022 (€ 106,594) Unfavourable step	€ 107,610 Retained profit 2024: € 107,610 ▲ 26% vs 2023 (€ 85,473) Favourable step	▲ 26%
Bank debt	€ 265,917 Bank debt 2021: € 265,917 First fiscal year in the series	€ 283,608 Bank debt 2022: € 283,608 ▲ 7% vs 2021 (€ 265,917) Unfavourable step	€ 233,998 Bank debt 2023: € 233,998 ▼ 17% vs 2022 (€ 283,608) Favourable step	€ 168,679 Bank debt 2024: € 168,679 ▼ 28% vs 2023 (€ 233,998) Favourable step	▼ 28%
Balance sheet total	€ 375,189 Balance sheet total 2021: € 375,189 First fiscal year in the series	€ 421,462 Balance sheet total 2022: € 421,462 ▲ 12% vs 2021 (€ 375,189) Unchanged	€ 356,433 Balance sheet total 2023: € 356,433 ▼ 15% vs 2022 (€ 421,462) Unchanged	€ 350,302 Balance sheet total 2024: € 350,302 ▼ 2% vs 2023 (€ 356,433) Unchanged	▼ 2%

Key figures of DR. T. SLANGEN, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to DR. T. SLANGEN?

What happened at DR. T. SLANGEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2025 New annual accounts for financial year 2024: profit of € 22,137. filed late Source: NBB ↗
2012 Thomas Hugo Slangen became a director. NBB
Jan 16, 2001 Start of the company according to the CBE. KBO
Jan 11, 2001 New establishment in Schoten. KBO

In short

From € 15,815 profit in 2021 to € 22,137 profit in 2024.

Paid € 26,392 in corporate taxes since 2021.

Best year ever: 2024, with € 22,137 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DR. T. SLANGEN? We notify you, reason included.

Follow DR. T. SLANGEN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Thomas Hugo Slangen

DR. T. SLANGEN

Behind DR. T. SLANGEN is Thomas Hugo Slangen.

See the full network in the app

Directors

According to the 2024 annual accounts

Thomas Hugo Slangen

Director

since 2012

Establishments

Establishment units

Physical locations of this company

Registered office

Alfons Servaislei 18 box 1

2900 Schoten

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.

All companies at this address →

Janula & De Romeo's

METECO

€ 205,832 gross margin · 2025

Vereniging van Mede-eigenaars van Residentie "Hof van Acaria" te Schoten, Alfons Servaislei 18

Slangen-Proost

Huisartsenpraktijk Taxandria

+1 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0473.830.251
VAT number: BE 0473.830.251
Registered office: Alfons Servaislei 18 bus 1, 2900 Schoten
Names & denominations: DR. T. SLANGEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 16 January 2001
Peppol: Active · Active since 1 Jan 2001

View on CBE Public ↗ Annual accounts (NBB) ↗